UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (1850) 1850
parkinsonian disorders - physiopathology (1840) 1840
life sciences & biomedicine (1802) 1802
neurosciences & neurology (1523) 1523
male (1407) 1407
animals (1365) 1365
neurosciences (1170) 1170
humans (1165) 1165
parkinson's disease (1041) 1041
female (783) 783
disease models, animal (656) 656
clinical neurology (629) 629
rats (620) 620
parkinsonian disorders - drug therapy (516) 516
parkinsonian disorders - pathology (484) 484
neurology (466) 466
parkinsonian disorders - chemically induced (462) 462
middle aged (451) 451
parkinsonian disorders - metabolism (435) 435
aged (431) 431
dopamine - metabolism (415) 415
mice (359) 359
rats, sprague-dawley (346) 346
dopamine (342) 342
substantia nigra - physiopathology (318) 318
parkinson’s disease (263) 263
oxidopamine (258) 258
parkinsonian disorders - genetics (254) 254
substantia nigra - drug effects (249) 249
corpus striatum - physiopathology (246) 246
parkinsonian disorders - diagnosis (246) 246
mice, inbred c57bl (241) 241
neurons - drug effects (238) 238
neurons - metabolism (234) 234
substantia nigra - metabolism (234) 234
parkinsonism (231) 231
motor activity - drug effects (223) 223
analysis (220) 220
adult (219) 219
brain - physiopathology (215) 215
rats, wistar (215) 215
tyrosine 3-monooxygenase - metabolism (211) 211
corpus striatum - drug effects (204) 204
neurons (204) 204
substantia nigra - pathology (203) 203
basal ganglia (200) 200
movement disorders (198) 198
corpus striatum - metabolism (197) 197
parkinson disease - physiopathology (194) 194
parkinsonian disorders - therapy (192) 192
nervous system (189) 189
parkinsonian disorders - complications (182) 182
brain - pathology (180) 180
neurons - pathology (174) 174
dose-response relationship, drug (169) 169
mptp (165) 165
aged, 80 and over (157) 157
6-hydroxydopamine (156) 156
parkinsons disease (155) 155
diagnosis, differential (149) 149
motor activity - physiology (149) 149
neurons - physiology (145) 145
abridged index medicus (144) 144
oxidopamine - toxicity (143) 143
antiparkinson agents - pharmacology (142) 142
nervous system diseases (140) 140
parkinsonian disorders - etiology (138) 138
time factors (137) 137
neural pathways - physiopathology (136) 136
neuroprotective agents - pharmacology (136) 136
corpus striatum - pathology (133) 133
substantia nigra (133) 133
psychiatry (131) 131
immunohistochemistry (130) 130
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (129) 129
nerve degeneration - physiopathology (129) 129
levodopa - pharmacology (128) 128
brain - metabolism (125) 125
treatment outcome (125) 125
magnetic resonance imaging (124) 124
biochemistry & molecular biology (121) 121
pharmacology & pharmacy (120) 120
behavior, animal - drug effects (119) 119
disease progression (118) 118
striatum (118) 118
antiparkinson agents - therapeutic use (112) 112
levodopa - therapeutic use (111) 111
dyskinesia, drug-induced - physiopathology (108) 108
research (104) 104
brain - drug effects (103) 103
neurodegenerative diseases (98) 98
parkinson disease (96) 96
medicine & public health (94) 94
brain (92) 92
parkinsonian disorders (92) 92
phenols (92) 92
neurodegeneration (89) 89
parkinsonian disorders - diagnostic imaging (88) 88
parkinsonian disorders - psychology (88) 88
physiological aspects (87) 87
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2198) 2198
Japanese (20) 20
French (19) 19
Russian (16) 16
Spanish (16) 16
German (12) 12
Hungarian (4) 4
Portuguese (4) 4
Chinese (3) 3
Italian (2) 2
Polish (2) 2
Ukrainian (2) 2
Dutch (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Movement disorders, ISSN 1531-8257, 12/2018, Volume 34, Issue 5, pp. 598 - 613
ABSTRACT There are several hundred single‐gene disorders that we classify as inborn errors of metabolism... 
inborn errors of metabolism | treatment | movement disorders | neurotransmitter disorders | neurogenetics | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Amino Acid Metabolism, Inborn Errors - complications | Niemann-Pick Disease, Type C - therapy | Hepatolenticular Degeneration - therapy | Monosaccharide Transport Proteins - deficiency | Amino Acid Metabolism, Inborn Errors - physiopathology | Humans | Folic Acid Deficiency - therapy | Hepatolenticular Degeneration - physiopathology | Vitamin E Deficiency - therapy | Dystonic Disorders - complications | Brain Diseases, Metabolic - diagnosis | Vitamin E Deficiency - diagnosis | Xanthomatosis, Cerebrotendinous - diagnosis | Basal Ganglia Diseases - diagnosis | Carbohydrate Metabolism, Inborn Errors - therapy | Dystonia - etiology | Carbohydrate Metabolism, Inborn Errors - diagnosis | Parkinsonian Disorders - physiopathology | Chorea - physiopathology | Dystonia - physiopathology | Metabolic Diseases - diagnosis | Ataxia - diagnosis | Carbohydrate Metabolism, Inborn Errors - physiopathology | Metabolism, Inborn Errors - diagnosis | Folic Acid Deficiency - complications | Movement Disorders - physiopathology | Brain Diseases, Metabolic - physiopathology | Basal Ganglia Diseases - therapy | Ataxia - complications | Muscle Spasticity - physiopathology | Xanthomatosis, Cerebrotendinous - complications | Metabolic Diseases - complications | Metabolism, Inborn Errors - complications | Metabolism, Inborn Errors - physiopathology | Brain Diseases, Metabolic - complications | Glutaryl-CoA Dehydrogenase - deficiency | Carbohydrate Metabolism, Inborn Errors - complications | Ataxia - etiology | Hepatolenticular Degeneration - diagnosis | Metabolism, Inborn Errors - therapy | Niemann-Pick Disease, Type C - physiopathology | Parkinsonian Disorders - etiology | Amino Acid Metabolism, Inborn Errors - diagnosis | Brain Diseases, Metabolic - therapy | Xanthomatosis, Cerebrotendinous - therapy | Metabolic Diseases - therapy | Metabolic Diseases - physiopathology | Myoclonus - etiology | Vitamin E Deficiency - complications | Niemann-Pick Disease, Type C - diagnosis | Dystonic Disorders - physiopathology | Dystonic Disorders - therapy | Hepatolenticular Degeneration - complications | Vitamin E Deficiency - physiopathology | Ataxia - physiopathology | Ataxia - therapy | Chorea - etiology | Amino Acid Metabolism, Inborn Errors - therapy | Basal Ganglia Diseases - complications | Folic Acid Deficiency - physiopathology | Myoclonus - physiopathology | Muscle Spasticity - etiology | Dystonic Disorders - diagnosis | Basal Ganglia Diseases - physiopathology | Movement Disorders - etiology | Xanthomatosis, Cerebrotendinous - physiopathology | Folic Acid Deficiency - diagnosis | Niemann-Pick Disease, Type C - complications | Dystonic Disorders - etiology | Metabolism, Inborn errors of | Education | Mortality | Finance | Physiological aspects | Creatine | Movement disorders | Energy metabolism | Inborn errors of metabolism | Lysosomal storage diseases | Metabolism | Autophagy | Morbidity | Quality of life | Phenomenology | Psychiatrists | Differential diagnosis | Children | Phagocytosis | Index Medicus
Journal Article
European archives of psychiatry and clinical neuroscience, ISSN 1433-8491, 05/2018, Volume 269, Issue 2, pp. 257 - 268
Journal Article
Journal Article